Official websites use .gov
A
.gov
website belongs to an official government organization in the
United States.
Secure .gov websites use HTTPS
A
lock
(
) or
https://
means you’ve safely connected to the .gov website. Share sensitive
information only on official, secure websites.
PubMed ID:
35360084
Public Release Type:
Journal
Publication Year: 2022
Affiliation: Division of Nephrology, Department of Medicine, University of California San Francisco, San Francisco, CA.; Division of Nephrology, Department of Medicine, University of California San Francisco, San Francisco, CA.; Division of Nephrology, Department of Medicine, University of California San Francisco, San Francisco, CA.; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.; Division of Nephrology, Department of Medicine, University of California San Francisco, San Francisco, CA.
DOI:
https://doi.org/10.1016/j.xkme.2022.100438
Authors:
Fallahzadeh Mohammad Kazem, Ku Elaine, Chu Chi D, McCulloch Charles E, Tuot Delphine S
Request IDs:
21726
Studies:
Folic Acid for Vascular Outcome Reduction in Transplantation Trial
Black kidney transplant recipients have higher prevalences of cardiovascular disease (CVD) risk factors and less intensive risk factor control than White kidney transplant recipients. Our objective was to evaluate racial disparities in receipt of statins and aspirin for secondary CVD prevention among kidney transplant recipients in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) trial.
